Eckert & Ziegler SE (ETR:EUZ)
15.14
+0.15 (1.00%)
At close: Mar 6, 2026
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 75.31M EUR in the quarter ending September 30, 2025, with 7.42% growth. This brings the company's revenue in the last twelve months to 304.47M, up 9.63% year-over-year. In the year 2024, Eckert & Ziegler SE had annual revenue of 295.85M with 20.22% growth.
Revenue (ttm)
304.47M
Revenue Growth
+9.63%
P/S Ratio
3.11
Revenue / Employee
273.80K
Employees
1,112
Market Cap
947.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
| Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
| Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
| Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
| Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.10B |
| Redcare Pharmacy NV | 2.94B |
| Gerresheimer AG | 2.25B |
| Carl Zeiss Meditec AG | 2.20B |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.95B |
Eckert & Ziegler SE News
- 1 day ago - EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 - Wallstreet:Online
- 11 days ago - EQS-AFR: Eckert & Ziegler SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 11 days ago - EQS-AFR: Eckert & Ziegler SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 4 weeks ago - Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY • news - Onvista
- 7 weeks ago - Eckert & Ziegler SE at JPMorgan Healthcare Conference Transcript - GuruFocus
- 3 months ago - EQS-News: Reorganization of the Eckert & Ziegler Executive Board - Wallstreet:Online
- 3 months ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - Eckert & Ziegler To Supply SK Biopharmaceuticals With Actinium-225 To Boost Research, Development - Finanz Nachrichten